# Eatris

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 27, 2026.

> EATRIS is the European infrastructure for translational medicine. We bring together resources and services for research communities to translate scientific discoveries into benefits for patients. We are a non-profit organisation that provides access to a vast array of expertise and facilities from over 175 top-tier academic centres across Europe. We focus on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcome barriers to health innovation.

- Business Profile: https://optimly.ai/brand/eatris
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://eatris.eu/
- Logo: https://logo.clearbit.com/eatris.eu
- Slug: eatris
- Category: Drug Discovery and Development Services
- Last Analyzed: August 27, 2026

## Buyer Intent Signals
Problems: Difficulty in translating scientific discoveries to patient benefits | Inefficient drug, vaccine, and diagnostic development | Barriers to health innovation | Lack of access to scientific & medical expertise and latest technologies for industry | Challenges in strengthening translational potential of research proposals | Need for education and training in translational medicine | Complexity of regulatory issues in biomedical development | Lack of access to regulatory, therapy development expertise, and manufacturing for rare disease researchers | Difficulty in assessing costs and benefits of complex health-related technologies | Challenges in assessing and optimizing translational feasibility of research projects | Need for legal support and partnering advice in research collaboration
Solutions: Access to translational medicine infrastructure | Research services for preclinical and early clinical development | Facilitation of industry-academia collaborations | Funding application support for researchers | Education and training in translational medicine | Regulatory services and support for biomedical development | Expert mentoring for rare disease research | Health Technology Assessment services | Translational Feasibility Assessment services | Innovation helpdesk for legal and partnering advice
Comparisons: Translational medicine expertise | Research infrastructure quality | Regulatory guidance for biomedical development | Academic-industry partnership opportunities | Support for grant applications | Rare disease therapy development support | Health technology value assessment | Intellectual property guidance for research | European research collaboration network